Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells

Endocrinology

Volumn 146, Issue 7, 2005, Pages 3059-3069

  Kogai, Takahiko ^a   Kanamoto, Yoko ^a   Li, Andrew I ^a   Che, Lisa H ^a   Ohashi, Emi ^a   Taki, Katsumi ^a,c   Chandraratna, Roshantha A ^b   Saito, Tsukasa ^c   Brent, Gregory A ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Vitae Pharmaceuticals   (United States)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGN 194204; AGN 194433; AGN 195183; ALITRETINOIN; CELL NUCLEUS RECEPTOR; DEXAMETHASONE; IODINE 131; LIGAND; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID DERIVATIVE; RETINOID X RECEPTOR; SODIUM IODIDE SYMPORTER; TAZAROTENE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CELL RECEPTOR; COTRANSPORTER; GLUCOCORTICOID; IODIDE; MESSENGER RNA; RADIOACTIVE IODINE; RETINOIC ACID; RETINOID;

ARTICLE; BREAST CANCER; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG HALF LIFE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ION TRANSPORT; PRIORITY JOURNAL; PROTEIN INDUCTION; BREAST TUMOR; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; DEXAMETHASONE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; IODIDES; IODINE RADIOISOTOPES; LIGANDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOIDS; RNA, MESSENGER; SYMPORTERS; TRETINOIN; TUMOR STEM CELL ASSAY;

EID: 22144497430     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1334     Document Type: Article

References (62)

1. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N 2000 The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871-878
2. Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak Jr WE, Mazzaferri EL, Jhiang SM 2000 Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936-2943
3. Perron B, Rodriguez AM, Leblanc G, Pourcher T 2001 Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J Endocrinol 170:185-196
4. Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohan O, Carrasco N 2003 Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 88:1880-1888
5. Moon DH, Lee SJ, Park KY, Park KK, Ahn SH, Pai MS, Chang H, Lee HK, Ahn I-M 2001 Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol 28:829-834
6. Upadhyay G, Singh R, Agarwal G, Mishra SK, Pal L, Pradhan PK, Das BK, Godbole MM 2003 Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue. Breast Cancer Res Treat 77:157-165
7. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T 1997 Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138:2227-2232
8. Taki K, Kogai T, Kanamoto Y, Hershman JM, Brent GA 2002 A thyroidspecific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3′,5′-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells. Mol Endocrinol 16:2266-2282
9. Kogai T, Schultz JJ, Johnson LS, Huang M, Brent GA 2000 Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line. Proc Natl Acad Sci USA 97:8519-8524
10. Dentice M, Luongo C, Elefante A, Romino R, Ambrosio R, Vitale M, Rossi G, Fenzi G, Salvatore D 2004 Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells. Mol Cell Biol 24:7863-7877
11. Tanosaki S, Ikezoe T, Heaney A, Said JW, Dan K, Akashi M, Koeffler HP 2003 Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells. Breast Cancer Res Treat 79:335-345
12. Chambon P 1994 The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol 5:115-125
13. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
14. Kogai T, Kanamoto Y, Che LH, Taki K, Moatamed F, Schultz JJ, Brent GA 2004 Systemic retinoic acid treatment induces sodium/iodide symporter expression and radioiodide uptake in mouse breast cancer models. Cancer Res 64:415-422
15. Hixson EJ, Burdeshaw JA, Denine EP, Harrison Jr SD 1979 Comparative subchronic toxicity of all-trans- and 13-cis-retinoic acid in Sprague-Dawley rats. Toxicol Appl Pharmacol 47:359-365
16. Brazzell RK, Vane FM, Ehmann CW, Colburn WA 1983 Pharmacokinetics of isotretinoin during repetitive dosing to patients. Eur J Clin Pharmacol 24:695-702
17. Spitzweg C, Joba W, Morris JC, Heufelder AE 1999 Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 9:821-830
18. Furlanetto TW, Nguyen LQ, Jameson JL 1999 Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 140:5705-5711
19. Medh RD, Schmidt TJ 1997 Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells. J Steroid Biochem Mol Biol 62:129-142
20. Tsai LC, Hung MW,Chen YH, Su WC, Chang GG, Chang TC 2000 Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells. Eur J Biochem 267:1330-1339
21. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP 1998 Ligands for peroxisome proliferatoractivated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95:8806-8811
22. Kogai T, Kanamoto Y, Brent GA 2003 The modified firefly luciferase reporter gene (luc+ ) but not Renilla luciferase is induced by all-trans retinoic acid in MCF-7 breast cancer cells. Breast Cancer Res Treat 78:119-126
23. Chandraratna RA 1996 Tazarotene-first of a new generation of receptorselective retinoids. Br J Dermatol 135(Suppl 49):18-25
24. Vuligonda V, Thacher SM, Chandraratna RA 2001 Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes. J Med Chem 44:2298-2303
25. Weiss SJ, Philp NJ, Grollman EF 1984 Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 114:1090-1098
26. Weiss SJ, Philp NJ, Grollman EF 1984 Effect of thyrotropin on iodide efflux in FRTL-5 cells mediated by Ca2+. Endocrinology 114:1108-1113
27. Shih TW, Shealy YF, Strother DL, Hill DL 1986 Nonenzymatic isomerization of all-trans- and 13-cis-retinoids catalyzed by sulfhydryl groups. Drug Metab Dispos 14:698-702
28. Kojima R, Fujimori T, Kiyota N, Toriya Y, Fukuda T, Ohashi T, Sato T, Yoshizawa Y, Takeyama K, Mano H 1994 In vivo isomerization of retinoic acids. Rapid isomer exchange and gene expression. J Biol Chem 269:32700-32707
29. Dai G, Levy O, Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460
30. Roy B, Taneja R, Chambon P 1995 Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RAR α)-, RAR β-, or RAR γ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell Biol 15:6481-6487
31. Horn V, Minucci S, Ogryzko VV, Adamson ED, Howard BH, Levin AA, Ozato K 1996 RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells. FASEB J 10:1071-1077
32. Wu S, Zhang D, Donigan A, Dawson MI, Soprano DR, Soprano KJ 1998 Effects of conformationally restricted synthetic retinoids on ovarian tumor cell growth. J Cell Biochem 68:378-388
33. Schmutzler C, Winzer R, Meissner-Weigl J, Kohrle J 1997 Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun 240:832-838
34. Knostman KA, Cho JY, Ryu KY, Lin X, McCubrey JA, Hla T, Liu CH, Di Carlo E, Keri R, Zhang M, Hwang DY, Kisseberth WC, Capen CC, Jhiang SM 2004 Signaling through 3′,5′-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer. J Clin Endocrinol Metab 89:5196-5203
35. Mandell RB, Mandell LZ, Link Jr CJ 1999 Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 59:661-668
36. O'Reilly MA, Clark JC, Whitsett JA 1991 Glucocorticoid enhances pulmonary surfactant protein B gene transcription. Am J Physiol 260:L37-L43
37. Boggaram V, Smith ME, Mendelson CR 1991 Posttranscriptional regulation of surfactant protein-A messenger RNA in human fetal lung in vitro by glucocorticoids. Mol Endocrinol 5:414-423
38. Karlan BY, Jones J, Slamon DJ, Lagasse LD 1994 Glucocorticoids stabilize HER-2/neu messenger RNA in human epithelial ovarian carcinoma cells. Gynecol Oncol 53:70-77
39. Murasawa S, Matsubara H, Kizima K, Maruyama K, Mori Y, Inada M 1995 Glucocorticoids regulate V1a vasopressin receptor expression by increasing mRNA stability in vascular smooth muscle cells. Hypertension 26:665-669
40. Baghdassarian N, Peiretti A, Devaux E, Bryon PA, Ffrench M 1999 Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes. Cell Growth Differ 10:405-412
41. Xie JF, Stroumza J, Graves DT 1994 IL-1 down-regulates platelet-derived growth factor-α receptor gene expression at the transcriptional level in human osteoblastic cells. J Immunol 153:378-383
42. Welcsh PL, Mankoff DA 2000 Taking up iodide in breast tissue. Nature 406:688-689
43. Daniels GH, Haber DA 2000 Will radioiodine be useful in treatment of breast cancer? Nat Med 6:859-860
44. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, Degroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896
45. Kilbane MT, Ajjan RA, Weetman AP, Dwyer R, McDermott EW, O'Higgins NJ, Smyth PP 2000 Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer. J Clin Endocrinol Metab 85:1245-1250
46. Idres N, Marill J, Flexor MA, Chabot GG 2002 Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers. J Biol Chem 277:31491-31498
47. Agarwal C, Chandraratna RA, Johnson AT, Rorke EA, Eckert RL 1996 AGN193109 is a highly effective antagonist of retinoid action in human ectocervical epithelial cells. J Biol Chem 271:12209-12212
48. Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P, Levin AA 1993 Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90:30-34
49. Lansink M, van Bennekum AM, Blaner WS, Kooistra T 1997 Differences in metabolism and isomerization of all-trans-retinoic acid and 9-cis-retinoic acid between human endothelial cells and hepatocytes. Eur J Biochem 247:596-604
50. Nagpal S, Athanikar J, Chandraratna RA 1995 Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J Biol Chem 270: 923-927
51. Blaner WS 2001 Cellular metabolism and actions of 13-cis-retinoic acid. J Am Acad Dermatol 45:S129-S135
52. Chen H, Juchau MR 1998 Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro. Biochem J 336(Pt 1):223-226
53. Moscow JA, Townsend AJ, Goldsmith ME, Whang-Peng J, Vickers PJ, Poisson R, Legault-Poisson S, Myers CE, Cowan KH 1988 Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci USA 85:6518-6522
54. Titcomb MW, Gottardis MM, Pike JW, Allegretto EA 1994 Sensitive and specific detection of retinoid receptor subtype proteins in cultured cell and tumor extracts. Mol Endocrinol 8:870-877
55. George TN, Miakotina OL, Goss KL, Snyder JM 1998 Mechanism of all trans-retinoic acid and glucocorticoid regulation of surfactant protein mRNA. Am J Physiol 274:L560-L566
56. Saji M, Kohn LD 1990 Effect of hydrocortisone on the ability of thyrotropin to increase deoxyribonucleic acid synthesis and iodide uptake in FRTL-5 rat thyroid cells: opposite regulation of adenosine 3′,5′- monophosphate signal action. Endocrinology 127:1867-1876
57. Venkateswaran A, Marsee DK, Green SH, Jhiang SM 2004 Forskolin, 8-Br-3′,5′-cyclic adenosine 5′-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/iodide symporter protein levels in RET/PTC1-expressing cells. J Clin Endocrinol Metab 89:6168-6172
58. Venkataraman GM, Yatin M, Ain KB 1998 Cloning of the human sodiumiodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50. Thyroid 8:63-69
59. Berlingieri MT, Santoro M, Battaglia C, Grieco M, Fusco A 1993 The adenovirus E1A gene blocks the differentiation of a thyroid epithelial cell line, however the neoplastic phenotype is achieved only after cooperation with other oncogenes. Oncogene 8:249-255
60. Ohta K, Pang XP, Berg L, Hershman JM 1996 Antitumor actions of cytokines on new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab 81:2607-2612
61. Kogai T, Hershman JM, Motomura K, Endo T, Onaya T, Brent GA 2001 Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells. Endocrinology 142:3369-3379
62. Elisei R, Vivaldi A, Agate L, Ciampi R, Molinaro E, Piampiani P, Romei C, Faviana P, Basolo F, Miccoli P, Capodanno A, Collecchi P, Pacini F, Pinchera A 2005 All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor β messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes. J Clin Endocrinol Metab 90:2403-2411